City
Epaper

India's Health Minister invites Global Investors from EXPO2020 to strengthen Make-in-India

By ANI | Updated: December 13, 2021 16:55 IST

India's Minister of Health and Family Welfare, Chemicals and Fertilizers, Dr Mansukh Mandaviya today invited global investors from the India Pavilion to invest and strengthen Make-in-India.

Open in App

India's Minister of Health and Family Welfare, Chemicals and Fertilizers, Dr Mansukh Mandaviya today invited global investors from the India Pavilion to invest and strengthen Make-in-India.

The Minister said, "Investors have tremendous opportunities in India because it is a strong democratic country, ease of doing business is a big facilitator, and under the leadership of Prime Minister Shri Narendra Modi, the pace of development has increased.

Middle class is expanding, and consumption power is rising. The Prime Minister has invited the global investors to come to the country and invest to strengthen Make-in-India."

On India's fightback against Corona, the Health Minister said, "India is a world leader in vaccine manufacturing sector. Two Indian companies have not only done the R&D but manufacturing of the vaccines also in the country. Our vaccine manufacturing capacity is 310 million doses per month and 86% of the population have got first dose of the vaccine while 55% of the population above 18 years of age have got the second dose. This is India's strength."

"PM Modi has further taken ahead the principle of Vasudhaiva Kutumbakam. We are providing 'India-made, India-researched' vaccines world over and helping everybody in getting protected against COVID," he added.

On India Pavilion, Dr Mandaviya said, "The Pavilion showcases India's rich culture and its 75 years of journey and provides detailed information on its industries and development. With its theme of a New and Self-reliant India, the Pavilion truly showcases the principle of Vasudhaiva Kutumbakam (the world is one family) and rich cultural heritage of India."

In his tweet message from the India Pavilion, Dr Mandaviya said, "Met @FICCI_India officials at the #IndiaPavilion of #Expo2020Dubai. Discussed various issues related to pharma & health sector. Modi Govt is relentlessly working towards transforming, strengthening health sector of India & is increasing its strength, self-reliance in the sector."

Dr Mandaviya also met H.E. Sultan Ahmed Bin Sulayem, Group Chairman and CEO, DP World and visited the pavilions of the UAE, the US and Saudi Arabia at EXPO2020.

To know more about India Pavilion at EXPO2020 Dubai, please visit

Website -

Facebook -

Instagram -

Twitter -

LinkedIn -

YouTube -

Koo -

To know more about EXPO2020 Dubai, please visit .

This story is provided by NewsVoir.will not be responsible in any way for the content of this article. (ANI/NewsVoir)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: DP WorldindiadubaiShri Narendra ModiFacebookState principalFacebook connectivityIndiUk-indiaAfter facebookNl salvi
Open in App

Related Stories

MumbaiDrug Kingpin Salman Sheikh Alias ‘Shera’ Extradited from Dubai; Key Accused in Pan-India Narcotics Racket

BusinessMukesh Ambani’s Reliance Industries Share Price Jump Over 2% as Facebook Acquires 30% Stake in AI Venture

TechnologyMeta Layoffs: Facebook-Owned Firm to Cut 600 Employees From AI Unit

MumbaiMumbai Crime Branch Arrests Close Aide of Notorious Drug Trafficker Salim Dola After Dubai Deportation

TechnologyCyber Crime Alert: How WhatsApp and Facebook Can Protect Your Money and Data from Scammers

Business Realted Stories

BusinessSensex, Nifty open flat amid mixed global cues

BusinessS. Korea unveils steps to support steel industry restructuring to overcome supply glut

BusinessSamsung to appeal $191.4 million jury verdict in US OLED patent dispute

BusinessConsumer staples companies see stable demand in Q2 FY26; GST transition, monsoon weigh on growth: Motilal Oswal

BusinessCorporate deals in country hit six-quarter high in Q3 CY25, recording USD 44.3 bn in transactions: PwC